GPC3 and neoplasm: Lastly, what exceeded our expectations is that adding GPC3-targeting immunotoxins into OHSV2-DSTEFAP5/CD3 and GPC3-targeting CAR T cells group resulted in a significant increase in the killing effect on tumor cells (Figure 5C).